$BOLD

TANG KEVIN sold $54K of BOLD (indirect holdings)

TANG KEVIN sold 18,300 indirectly-held shares of Boundless Bio, Inc. (BOLD) at $2.97 on 2026-08-26. Filed jointly with TANG CAPITAL MANAGEMENT LLC (10% owner).

Original reporting
SEC EDGAR · TANG KEVIN, TANG CAPITAL MANAGEMENT LLC
Published Aug 28, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 8:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BOLD
Neutral
medium confidence
Mentioned
$BOLD
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BOLDNeutralLow
01

Why it matters

A $54k sale by a 10% owner is unlikely to move the stock materially but may be noted by short‑term traders.

02

Market read

Small insider sale with limited trading impact; primarily of interest to ownership‑tracking investors.

03

What to watch

Potential upcoming clinical data or financing events not disclosed in the filing.

Relevance 3/10Novelty 4/10Timing: filing date 2026-08-28

Background

Form 4 filings disclose insider transactions and are primary sources for ownership changes.

Company-level read

Ticker impact

$BOLDNeutralMedium confidence
Context

Insider Kevin Tang sold 18,300 shares of Boundless Bio (BOLD) for $54,351 in a Form 4 filing dated 2026‑08‑26.

Expected impact

Minor short‑term dip or flat price action.

Evidence & confidence

The transaction size ($54k) is small relative to market cap; insider ownership remains sizable, so market reaction is expected to be muted.

Market effects

None significant; biotech sector unchanged.

No regional effect.

Minimal.

Counterpoint

The sale could signal confidence if the insider plans to re‑acquire later at lower prices.

Key entities

  • Kevin Tang

    10% owner of Boundless Bio, Inc.

  • Boundless Bio, Inc.

    Biotech firm trading under ticker BOLD.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DELLLow

Silver Lake Partners V DE (AIV), L.P. (Durban Egon) sold $14.9M of DELL (indirect holdings)

Silver Lake Partners V DE (AIV), L.P. sold 26,990 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $552.79 ($542.78–$564.46, $14.92M total) across 22 trades on 2026-09-15. Filed jointly with Silver Lake Technology Associates V, L.P. (Director), SLTA V (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).